MILLENNIUM MANAGEMENT LLC

Position in RCUS — Arcus Biosciences, Inc.

CIK 1273087 NEW YORK, NY

Back to RCUS Full portfolio

Position in RCUS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,103,781

+$79,466 QoQ

Shares Held

133,110

-21.2% QoQ

Ownership

0.105%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#63

of 230 holders

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in RCUS Over Time

Shares Held

Position Value (USD)

Derivatives in RCUS

reported options exposure · as of Jun 30, 2024

CallValue

$767,592

CallShares

50,400

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. RCUS ranks #180 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	468,410	$232,673,299
2	INSM	INSMED Inc	2,048,005	$218,358,293
3	APGE	Apogee Therapeutics, Inc.	1,491,404	$197,954,052
4	JAZZ	Jazz Pharmaceuticals plc	763,880	$184,072,163
5	ONC	BeOne Medicines Ltd.	543,323	$154,830,755
6	AXSM	Axsome Therapeutics, Inc.	556,088	$136,113,659
7	BMRN	Biomarin Pharmaceutical Inc	2,071,816	$118,549,311
8	REGN	Regeneron Pharmaceuticals, Inc.	165,120	$102,958,924

All Filings in RCUS

Export CSV

42 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,103,781	133,110	-21.2%	Shares	Sole	2026-08-14
2025-12-31	$4,024,315	168,876	-73.4%	Shares	Sole	2026-02-17
2025-09-30	$8,635,238	634,944	-18.6%	Shares	Sole	2025-11-14
2025-06-30	$6,349,916	780,088	-34.7%	Shares	Sole	2025-08-14
2025-03-31	$9,377,782	1,194,622	+29.2%	Shares	Sole	2025-05-15
2024-12-31	$13,763,854	924,369	+277.1%	Shares	Sole	2025-02-14
2024-09-30	$3,747,609	245,102	+39.5%	Shares	Sole	2024-11-14
2024-06-30	$767,592	50,400	+0.8%	Call	Sole	2024-08-14
2024-06-30	$2,675,987	175,705	+459.7%	Shares	Sole	2024-08-14
2024-03-31	$944,000	50,000	-78.4%	Call	Sole	2024-05-15
2023-12-31	$599,625	31,394	-68.7%	Shares	Sole	2024-02-14
2023-09-30	$1,798,195	100,178	+81.0%	Shares	Sole	2023-11-14
2023-09-30	$4,151,835	231,300	+12.7%	Call	Sole	2023-11-14
2023-06-30	$1,124,056	55,345	-61.7%	Shares	Sole	2023-08-14
2023-06-30	$4,169,643	205,300	+86.6%	Call	Sole	2023-08-14
2023-03-31	$2,006,400	110,000	0.0%	Call	Sole	2023-05-15
2022-12-31	$843,744	40,800	-60.1%	Put	Sole	2023-02-14
2022-12-31	$2,274,800	110,000	+115.7%	Call	Sole	2023-02-14
2022-12-31	$2,990,886	144,627	+1051.4%	Shares	Sole	2023-02-14
2022-09-30	$328,595	12,561	-89.9%	Shares	Sole	2022-11-14
2022-09-30	$1,334,160	51,000	-55.8%	Call	Sole	2022-11-14
2022-06-30	$2,592,282	102,300	-27.9%	Put	Sole	2022-08-15
2022-06-30	$3,136,078	123,760	+386.2%	Shares	Sole	2022-08-15
2022-06-30	$2,921,702	115,300	-53.7%	Call	Sole	2022-08-15
2022-03-31	$803,422	25,457	-65.5%	Shares	Sole	2022-05-16
2022-03-31	$7,858,440	249,000	+162.1%	Call	Sole	2022-05-16
2022-03-31	$4,478,364	141,900	+1319.0%	Put	Sole	2022-05-16
2021-12-31	$2,990,530	73,895	+529.2%	Shares	Sole	2022-02-14
2021-12-31	$3,844,650	95,000	+216.7%	Call	Sole	2022-02-14
2021-09-30	$409,513	11,744	-93.2%	Shares	Sole	2021-11-15
2021-09-30	$1,046,100	30,000	+100.0%	Call	Sole	2021-11-15
2021-06-30	$4,743,220	172,732	+522.2%	Shares	Sole	2021-08-16
2021-06-30	$411,900	15,000	+50.0%	Call	Sole	2021-08-16
2021-03-31	$779,585	27,763	+64.6%	Shares	Sole	2021-05-17
2021-03-31	$280,800	10,000	0.0%	Call	Sole	2021-05-17
2021-03-31	$280,800	10,000	0.0%	Put	Sole	2021-05-17
2020-12-31	$259,600	10,000	—	Put	Sole	2021-02-16
2020-12-31	$259,600	10,000	—	Call	Sole	2021-02-16
2020-12-31	$437,997	16,872	-94.4%	Shares	Sole	2021-02-16
2020-09-30	$5,193,917	303,029	-35.4%	Shares	Sole	2020-11-16
2020-06-30	$11,613,129	469,407	+3.5%	Shares	Sole	2020-08-14
2020-03-31	$6,297,189	453,688	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.